Research and analysis

Regenerative medicine in the UK: taking stock

Assesses the state of the regenerative medicine field internationally and analyses the UK’s strengths, weaknesses and areas of opportunity. …

Document

Detail

Assesses the state of the regenerative medicine field internationally and analyses the UK’s strengths, weaknesses and areas of opportunity. Identifies key barriers to the therapeutic and commercial use of regenerative medicines and sets out how government will work to overcome them. Aims to provide a strong evidence base for the government to coordinate funding decisions, and to lay the ground-work for an agreed strategy for regenerative medicine. See also reports on bibliometric analysis (URN 11/1059) and the patent landscape (11/1087).